Quantamental Technologies LLC Atara Biotherapeutics, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$12.03 - $19.94 $10,670 - $17,686	-887 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$19.05 - $41.04 $16,897 - $36,402	887 New	887 $18,000
Q1 2019 Apr 29, 2019	SELL	$28.4 - $41.74 $50,637 - $74,422	-1,783 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$30.9 - $42.97 $55,094 - $76,615	1,783 New	1,783 $62,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.